Fischer Medical Ventures Ltd
NSE: FISCHER BSE: 524743
Fischer Medical Ventures Ltd (FISCHER) is a Diversified company listed on NSE: FISCHER | BSE: 524743. With a market cap of ₹2,278 Cr and ROCE of 0.5%, ROE of 0.32%, it operates in the Indian Diversified sector.
₹34.8
52W: ₹32 — ₹125
PE 0 · Book ₹5.22 · +567% vs bookMarket Cap₹2,278 Cr
Stock P/E—Price to Earnings
ROCE0.5%Return on Capital
ROE0.32%Return on Equity
Div. Yield0.01%Face Value ₹1
Weaknesses
- −Stock is trading at 6.53 times its book value
- −Company has low interest coverage ratio.
- −Earnings include an other income of Rs.3.74 Cr.
- −Company has high debtors of 1,194 days.
- −Working capital days have increased from 597 days to 1,408 days
Shareholding Pattern
Promoters62.15%
FIIs4.97%
DIIs1.38%
Public31.51%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 74.91% | 74.91% | 74.91% | 62.82%▼12.1 | 61.8%▼1.0 | 61.8% | 61.8% | 62.15%▲0.4 |
| FIIs | 5.07% | 5.07% | 5.07% | 5.23%▲0.2 | 5.55%▲0.3 | 5.57%▲0.0 | 4.85%▼0.7 | 4.97%▲0.1 |
| DIIs | 1.68% | 1.68% | 1.68% | 1.44%▼0.2 | 1.42%▼0.0 | 1.42% | 1.36%▼0.1 | 1.38%▲0.0 |
| Public | 18.33% | 18.33% | 18.32%▼0.0 | 30.51%▲12.2 | 31.23%▲0.7 | 31.22%▼0.0 | 31.99%▲0.8 | 31.51%▼0.5 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.19 | 0 | 11.34 | 0 | 0 | 0 | 5.22 | 4.54 | 7.43 | 1.32 |
| Expenses | 0.04 | 0.14 | 11.43 | 0.11 | 0.36 | 0.22 | 6.78 | 4.16 | 6.28 | 2.64 |
| Operating Profit | 0.15 | -0.14 | -0.09 | -0.11 | -0.36 | -0.22 | -1.56 | 0.38 | 1.15 | -1.32 |
| OPM % | 78.95% | 0% | -0.79% | 0% | 0% | 0% | -29.89% | 8.37% | 15.48% | -100% |
| Net Profit | 0.14 | -0.13 | 0.6 | 0.84 | 0.51 | 0.2 | -0.89 | -0.61 | 0.84 | -1.67 |
| EPS ₹ | 0.06 | -0.05 | 0.01 | 0.02 | 0.01 | 0 | -0.01 | -0.01 | 0.01 | -0.03 |
AI Insights
Revenue Trend
TTM revenue at ₹18.51Cr, up 254.6% YoY. OPM at -7.29%.
Debt Position
Borrowings at ₹36.95Cr. Debt-to-equity ratio: 0.14x. Healthy balance sheet.
Institutional Flow
DIIs: 1.38% (+1.38pp change). FIIs: 4.97% (+4.97pp change). Promoters hold 62.15%.
Margin & Efficiency
ROCE improving from 0% (Mar 2014) to 0.5% (Mar 2025). Working capital days: 1407.56.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Monitoring Agency Report 2d - Q4FY26 monitoring report shows Rs. 280.93 crore utilised; no deviation from preferential issue objects.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 2d - Newspaper Advertisement- Special Window for Re-lodgement of Transfer requests for physical shares
- Announcement under Regulation 30 (LODR)-Press Release / Media Release 14 May - WFNS committee partners with Fischer subsidiary Time Medical India on neurosurgical innovation collaboration.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Apr - Regulation 74(5) certificate filed for quarter ended 31 March 2026.
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 1 Apr
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse